Japanese experience with second-line chemotherapy with low-dose (60 mg/m) docetaxel in patients with advanced non-small-cell lung cancer

By Mukohara Toru   Takeda Koji   Miyazaki Masaki   Takifuji Nobuhide   Terakawa Kazuhiko   Negoro Shunichi  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 356-360

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between low dose-rate irradiation, mild hyperthermia and low-dose caffeine in a human lung cancer cell line

By Sakurai H.   Mitsuhashi N.   Tamaki Y.   Akimoto T.   Murata O.   Kitamoto Y.   Maebayashi K.   Ishikawa H.   Hayakawa K.   Niibe H.  

International Journal of Radiation Biology, Vol. 75, Iss. 6, 1999-06 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 2057-2063

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma

By Niioka Takenori   Uno Tsukasa   Yasui-Furukori Norio   Takahata Takenori   Shimizu Mikiko   Sugawara Kazunobu   Tateishi Tomonori  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 575-580

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite